EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway

Yong-Yu Yang iD, Rong-Rong Deng, Da-Xiong Xiang

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s443479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yong-Yu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Rats, Sprague-Dawley, Reperfusion Injury, MAP Kinase Signaling System. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisRats, Sprague-DawleyReperfusion InjuryMAP Kinase Signaling SystemDrugs, Chinese HerbalAnimalsRatsMaleBrain IschemiaInfarction, Middle Cerebral ArteryDisease Models, AnimalNeuroprotective Agents

Stichwörter der Autor:innen

Naodesheng pillscerebral ischemia/reperfusionferroptosisglutathione peroxidase 4mitogen-activated protein kinase 1/2

Substanzen

Drugs, Chinese HerbalNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
  • Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
  • School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.

ORCID-Profile: Yong-Yu Yang

Zitieren

APA

Yang, Y. Y., Deng, R. R., & Xiang, D. X. (2024). Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s443479

Vancouver

Yang YY, Deng RR, Xiang DX. Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s443479

BibTeX
@article{Yang2024,
  author = {Yang, Yong-Yu and Deng, Rong-Rong and Xiang, Da-Xiong},
  title = {Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s443479}
}
Kostenlos starten →